Compare Bank of Montreal (BMO) vs Summit Therapeutics Inc (SMMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bank of Montreal vs Summit Therapeutics Inc — how do they compare? Bank of Montreal trades at $182.04 (market cap $126.83B), while Summit Therapeutics Inc trades at $15.35 (market cap $12.06B). The key difference: Bank of Montreal is far larger — about 10.5× Summit Therapeutics Inc's market cap, and Bank of Montreal pays a 2.69% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| BMO | SMMT | |
|---|---|---|
Market Cap | $126.83B | $12.06B |
Sector | Financials | Health |
52-Week High | $183.65 | $26.98 |
52-Week Low | $112.54 | $12.55 |
Dividend Yield | 2.69% | — |
Enterprise Value | — | $11.39B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Bank of Montreal
Bank of Montreal is a diversified financial-services provider based in North America, operating four business segments: Canadian personal and commercial banking, U.S. P&C banking, wealth management, and capital markets. The bank's operations are primarily in Canada, with a material portion also in the U.S.
Read more on BMO →About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →
